QuidelOrtho Reaffirms FY23 Sales Guidance Of $2.88B-$3.08B Versus Consensus Of $2.98B, With Adjusted EPS Of $4.85-$5.30 Versus Consensus Of $4.90
Portfolio Pulse from Benzinga Newsdesk
QuidelOrtho has reaffirmed its FY23 sales guidance of $2.88B-$3.08B, which is in line with the consensus of $2.98B. The company also expects an adjusted EPS of $4.85-$5.30, slightly above the consensus of $4.90.
October 12, 2023 | 11:36 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
QuidelOrtho's reaffirmed FY23 sales guidance and higher expected EPS could potentially have a positive impact on its stock (QDEL).
QuidelOrtho's reaffirmed sales guidance indicates stability and confidence in its business outlook. The higher expected EPS suggests potential for increased profitability, which could positively impact the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100